BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3111616)

  • 21. Occult faecal blood loss determined by a 51Cr method and chemical tests in patients referred for colonoscopy.
    Dybdahl JH; Daae LN; Larsen S; Myren J
    Scand J Gastroenterol; 1984 Mar; 19(2):245-54. PubMed ID: 6609422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical testing for faecal occult blood in patients with colorectal cancer.
    McDonald C; Burford Y; Walls R; Goulston K
    Med J Aust; 1985 Aug; 143(4):141-3. PubMed ID: 3927121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A control trial of faecal occult blood screening for colorectal cancer: 2-year results.
    Hardcastle JD; Armitage NC; Chamberlain J; Balfour TW; Amar SS
    Br J Surg; 1985 Sep; 72 Suppl():S69-71. PubMed ID: 3899267
    [No Abstract]   [Full Text] [Related]  

  • 24. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult blood in colorectal cancer.
    Gastroenterology; 1985 Sep; 89(3):704-6. PubMed ID: 4018512
    [No Abstract]   [Full Text] [Related]  

  • 26. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective study of same day bi-directional endoscopy in the evaluation of patients with occult gastrointestinal bleeding.
    Stray N; Weberg R
    Scand J Gastroenterol; 2006 Jul; 41(7):844-50. PubMed ID: 16785199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Screening for colorectal cancer with a test for occult blood in stool (author's transl)].
    Uhlig K; Jacobasch KH; Lampe J; Wiedemann FH; Schönberner H
    Arch Geschwulstforsch; 1981; 51(8):717-20. PubMed ID: 7340717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Faecal occult blood tests in adenoma detection.
    Kronborg O
    Eur J Cancer Prev; 1993 Jun; 2 Suppl 2():107-10. PubMed ID: 8364366
    [No Abstract]   [Full Text] [Related]  

  • 30. Five guaiac-based tests for occult blood in faeces compared in vitro and in vivo.
    Adlercreutz H; Partanen P; Virkola P; Liewendahl K; Turunen MJ
    Scand J Clin Lab Invest; 1984 Oct; 44(6):519-28. PubMed ID: 6333067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an immunological test for occult bleeding from colorectal neoplasia.
    Williams JA; Hunter R; Smith M; Coles ME; Hubert TW; Thomas DW
    Aust N Z J Surg; 1982 Dec; 52(6):617-21. PubMed ID: 6819850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative frequency of upper gastrointestinal and colonic lesions in patients with positive fecal occult-blood tests.
    Rockey DC; Koch J; Cello JP; Sanders LL; McQuaid K
    N Engl J Med; 1998 Jul; 339(3):153-9. PubMed ID: 9664091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing.
    Doran J; Hardcastle JD
    Br J Surg; 1982 Dec; 69(12):711-3. PubMed ID: 7171971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editorial: It's time to make organized colorectal cancer screening convenient and easy for patients.
    Levin TR
    Am J Gastroenterol; 2009 Apr; 104(4):939-41. PubMed ID: 19293790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test].
    Schellenberger U; Raabe A; Erler K
    Z Arztl Fortbild (Jena); 1987; 81(20):1057-9. PubMed ID: 3433823
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
    Hippisley-Cox J; Coupland C; Logan R
    BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Questions about occult-blood screening for cancer.
    Lancet; 1986 Jan; 1(8471):22. PubMed ID: 2867267
    [No Abstract]   [Full Text] [Related]  

  • 39. Inappropriate and improper use of fecal occult blood tests for colorectal cancer screening in the VA Medical System.
    Ahmed F; Murthy UK
    Am J Gastroenterol; 2006 Jun; 101(6):1401. PubMed ID: 16771975
    [No Abstract]   [Full Text] [Related]  

  • 40. [Digestive hemorrhage following gastroduodenal ulcers caused by non-steroidal anti-inflammatory agents].
    Raoul JL; Emery P; Bretagne JF; Chaperon J; Bansard JY; Siproudhis L; Gosselin M
    Gastroenterol Clin Biol; 1991; 15(12):950-5. PubMed ID: 1783251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.